Stockscreener 앱 받기
22.33
0.95%
-0.2434
전일 마감가:
$22.57
열려 있는:
$23.25
하루 거래량:
194.99K
Relative Volume:
0.09
시가총액:
$1.55B
수익:
$1.03B
순이익/손실:
$-94.55M
주가수익비율:
-15.93
EPS:
-1.4012
순현금흐름:
$-3.64M
1주 성능:
-1.61%
1개월 성능:
+27.02%
6개월 성능:
-9.02%
1년 성능:
+102.31%
1일 변동 폭
$22.06
$23.25
1주일 범위
$21.70
$24.81
52주 변동 폭
$11.16
$29.65
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
명칭
Tandem Diabetes Care Inc
전화
858-366-6900
주소
12400 HIGH BLUFF DRIVE, San Diego, CA
Compare TNDM vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
22.30 | 1.63B | 1.03B | -94.55M | -3.64M | -1.4012 |
ABT
Abbott Laboratories
|
116.00 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.14 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
93.19 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
50.44 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.25 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-19 | 업그레이드 | Truist | Hold → Buy |
| 2026-03-17 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2026-02-23 | 업그레이드 | Lake Street | Hold → Buy |
| 2026-02-20 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2026-01-27 | 재개 | TD Cowen | Buy |
| 2025-12-16 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-10-21 | 재개 | Stifel | Hold |
| 2025-09-08 | 개시 | Oppenheimer | Outperform |
| 2025-08-12 | 업그레이드 | Citigroup | Sell → Neutral |
| 2025-08-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2025-06-16 | 개시 | Truist | Hold |
| 2025-04-10 | 개시 | Mizuho | Neutral |
| 2025-03-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-03-03 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | 개시 | Bernstein | Outperform |
| 2024-10-04 | 개시 | Goldman | Neutral |
| 2024-10-02 | 개시 | RBC Capital Mkts | Outperform |
| 2024-08-22 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-08-08 | 개시 | Canaccord Genuity | Buy |
| 2024-05-30 | 개시 | Redburn Atlantic | Buy |
| 2024-05-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-04-29 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | 업그레이드 | Stifel | Hold → Buy |
| 2023-08-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-05-05 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-04-24 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-01-26 | 개시 | Wolfe Research | Peer Perform |
| 2022-11-15 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-08-09 | 다운그레이드 | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-25 | 개시 | Barclays | Underweight |
| 2020-12-15 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | 개시 | Wells Fargo | Overweight |
| 2020-07-31 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-07-06 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-06-18 | 재확인 | Raymond James | Outperform |
| 2020-04-24 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-06 | 개시 | Raymond James | Outperform |
| 2020-02-04 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | 개시 | Guggenheim | Buy |
| 2019-10-04 | 업그레이드 | UBS | Neutral → Buy |
| 2019-05-17 | 재확인 | BofA/Merrill | Neutral |
| 2019-05-13 | 개시 | SVB Leerink | Outperform |
| 2019-03-08 | 개시 | BMO Capital Markets | Outperform |
| 2019-03-05 | 재확인 | BofA/Merrill | Neutral |
| 2019-02-27 | 재확인 | Lake Street | Buy |
| 2018-11-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | 재확인 | Dougherty & Company | Buy |
| 2018-09-26 | 재확인 | Piper Jaffray | Overweight |
모두보기
Tandem Diabetes Care Inc 주식(TNDM)의 최신 뉴스
William Blair initiates Tandem Diabetes stock with outperform rating By Investing.com - Investing.com Canada
Why Did TNDM Stock Jump 5% After Hours Despite Q4 Earnings Miss? - Stocktwits
Tandem Diabetes (TNDM) Q2 2026 Earnings Call Transcript - AOL.com
How Tandem’s Q2 Loss and Pharmacy Pivot Will Impact Tandem Diabetes Care (TNDM) Investors - simplywall.st
Tandem (TNDM) Earnings Brief: Profit Per Share Clears Its Benchmark in the Current Update; Price Action: Shares Finish 6.63% Up at the CloseEarnings Season Preview - Vinanet
Tandem Diabetes Care CFO Leigh Vosseller Reports RSU Vesting Transactions on August 15, 2026 - Kalkine Media
Tandem Diabetes Care CEO John F. Sheridan Reports August 2026 RSU Vesting and Tax Withholding Details - Kalkine Media
Tandem Diabetes Care | 4: Statement of changes in beneficial ownership of securities-Officer Morrison Susan - Moomoo
Tandem Diabetes (TNDM) CFO vests RSUs as shares withheld for tax - Stock Titan
Tandem Diabetes (NASDAQ: TNDM) exec nets 475 shares after RSU vesting - Stock Titan
Tandem Diabetes (NASDAQ: TNDM) CEO vests 15,916 RSUs as shares withheld for tax - Stock Titan
Tandem Diabetes Care | 4: Statement of changes in beneficial ownership of securities-Officer Kyrillos Jean-Claude - Moomoo
Tandem Diabetes (NASDAQ: TNDM) CSO vests 3,014 RSUs, 1,618 withheld - Stock Titan
Tandem Diabetes (NASDAQ: TNDM) CLO RSUs vest, with shares withheld for taxes - Stock Titan
Tandem Diabetes (NASDAQ: TNDM) CTO withholds 1,277 shares to cover RSU taxes - Stock Titan
Tandem Diabetes (NASDAQ: TNDM) holder to sell 131 RSU shares - Stock Titan
Tandem Diabetes Care Maps Growth Plan With Pharmacy Shift and Tubeless Mobi - Yahoo Finance
Tandem Diabetes Care Inc (TNDM) (Q2 2026) Earnings Call Highligh - GuruFocus
Tandem Diabetes Care Inc (TNDM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Renaissance Technologies LLC Purchases New Position in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Tandem Diabetes Care (NASDAQ:TNDM) Shares Cross Above 200-Day Moving AverageTime to Sell? - marketbeat.com
5 Must-Read Analyst Questions From Tandem Diabetes’s Q2 Earnings Call - Yahoo Finance
TNDM|Tandem Diabetes Care Inc|Price:22.617|Chg%:-0.513 - TradingKey
(TNDM) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Tandem Diabetes Care, Inc. (TNDM) Stock Forecasts - Yahoo Finance
TNDM Q2 Loss Narrower Than Expected, Revenues Miss, Stock Up - The Globe and Mail
Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Analyzing 25% Potential Upside with No Sell Ratings - DirectorsTalk Interviews
Tandem Diabetes Care Inc (TNDM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Why Tandem Diabetes (TNDM) Stock Is Trading Up Today - Yahoo Finance
TNDM Q2 Deep Dive: Pharmacy Channel Gains and Pipeline Execution Amid Margin Recovery - Yahoo Finance
Tandem Diabetes Care, Inc. (TNDM) Stock forecasts - Yahoo Finance UK
Why Tandem Diabetes Care (TNDM) Is Up 14.8% After Record Q2 Sales And PayGo Momentum - finance.yahoo.com
Tandem Diabetes Care (TNDM) Could Be 23% Below Fair Value After Q2 Results - Yahoo Finance
TNDM Maintained by Citigroup -- Price Target Raised to $21.00 - GuruFocus
Tandem Diabetes Care (NASDAQ:TNDM) Announces Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Deutsche Bank Adjusts Tandem Diabetes Care PT to $18 From $15.50, Maintains Hold Rating - Moomoo
Oppenheimer reiterates Tandem Diabetes stock rating on pharmacy gains By Investing.com - Investing.com South Africa
TNDM Maintained by RBC Capital -- Price Target Lowered to $26 - GuruFocus
Tandem Diabetes Care Is Maintained at Outperform by RBC Capital - Moomoo
Tandem Diabetes Care, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:TNDM) 2026-08-07 - Seeking Alpha
Tandem Diabetes Care's Underlying Q2 Trends Better Than Headline Suggests, RBC Says - marketscreener.com
Tandem Diabetes Care Q2 Earnings Call Highlights - MarketBeat
Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap DownWhat's Next? - MarketBeat
Tandem Diabetes Care Inc (TNDM) Stock News Today - TradingKey
Tandem Diabetes Care, Inc. Stock 12‑Month Price Target Raised to $29.5, Implies 57% Upside - TradingView
RBC Adjusts PT on Tandem Diabetes Care to $26 From $30, Maintains Outperform Rating - marketscreener.com
Tandem Diabetes Care, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Tandem Diabetes Care Announces Second Quarter 2026 Financial Results - BioSpace
Tandem Diabetes Care earnings beat by $0.02, revenue fell short of estimates - Investing.com Canada
Earnings call transcript: Tandem Diabetes Care posts Q2 2026 profit beat - Investing.com Nigeria
TNDM Looks 37.4% Undervalued on GF Value™ Despite Unprofitable S - GuruFocus
Tandem Diabetes Care Inc (TNDM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.76%
자본화:
|
볼륨(24시간):